Beta-Funaltrexamine

Beta-Funaltrexamine (β-FNA) is a derivative of morphine that is used in scientific research. It is an irreversible opioid antagonist that has been widely used in the study of opioid receptors.

Chemistry

Beta-Funaltrexamine is a morphinan derivative, which is a class of chemical compounds that includes many opioids. It is structurally similar to morphine, but with a functional group replaced to create a compound that acts as an antagonist rather than an agonist.

Pharmacology

Beta-Funaltrexamine acts as an irreversible antagonist at mu-opioid receptors, meaning that once it has bound to a receptor, it will not unbind. This makes it a useful tool in the study of these receptors, as it allows researchers to 'turn off' the receptors for an extended period of time and observe the effects.

Uses in Research

Beta-Funaltrexamine has been used in a wide range of research studies. These have included studies into the role of mu-opioid receptors in pain perception, addiction, and other neurological processes. It has also been used to investigate the effects of long-term opioid use and the mechanisms of opioid tolerance and dependence.

Safety

As with all opioids, beta-Funaltrexamine has the potential to cause side effects. However, as it is used primarily in research rather than in clinical practice, these risks are generally managed by the researchers conducting the studies.

See Also

• Opioid receptor
• Morphine
• Opioid antagonist

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian